MiR-30a-5p Inhibits Proliferation and Metastasis of Hydatidiform Mole by Regulating B3GNT5 Through ERK/AKT Pathways

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2020 Jun 24

PMID 32575164

Citations 5

Authors

Zhenzhen Guo

Qiannan Sun

Yangyou Liao

Chao Liu

Wenjie Zhao

Xiaoxue Li

Huan Liu

Ming Dong

Yuhong Shang

Linlin Sui

Ying Kong

Affiliations

Soon will be listed here.

Abstract

Hydatidiform moles are gestational trophoblastic disease. They are abnormal proliferations of trophoblast cells that have the potential to become cancerous. miR-miR30a-5p is a tumour suppressor that participates in the development of numerous diseases. However, the role of miR-30a in hydatidiform moles and the mechanisms underlying its effects are presently unclear. This study explored the levels of miR-30a and B3GNT5 expression in human hydatidiform mole tissue. The results showed that miR-30a and B3GNT5 were differentially expressed in normal placenta and hydatidiform mole, and miR-30a decreased cell proliferation, invasion and migration in trophoblast cell lines. Upon further examination, it was confirmed that miR-30a directly targeted the 3'untranslated region of B3GNT5 using a dual-luciferase assay. The results of the present study also revealed that miR-30a reduced the proliferation, invasion and migration ability in JAR and BeWo cells by regulating B3GNT5, which may inactivate the ERK and AKT signalling pathways. This study demonstrated that miR-30a was a novel target B3GNT5 that serves an important role in the development of hydatidiform moles, suggesting that miR-30a may serve as a novel potential biomarker or useful diagnostic and therapeutic tool for hydatidiform moles in clinical settings.

Citing Articles

Impacts of β-1, 3-N-acetylglucosaminyltransferases (B3GNTs) in human diseases.

Xie A, Wang J, Liu Y, Li G, Yang N Mol Biol Rep. 2024; 51(1):476.

PMID: 38553573 DOI: 10.1007/s11033-024-09405-9.

PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?.

Parker V, Winter M, Tidy J, Hancock B, Palmer J, Sarwar N Int J Cancer. 2022; 152(5):986-997.

PMID: 36346113 PMC: 10108153. DOI: 10.1002/ijc.34352.

miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways.

Guo Z, Zhu C, Wang Y, Li Z, Wang L, Fan J Cancer Cell Int. 2022; 22(1):103.

PMID: 35246136 PMC: 8895545. DOI: 10.1186/s12935-022-02503-3.

Circular RNA PUM1 (CircPUM1) attenuates trophoblast cell dysfunction and inflammation in recurrent spontaneous abortion via the MicroRNA-30a-5p (miR-30a-5p)/JUNB axis.

Zhu L, Shi L, Ye W, Li S, Liu X, Zhu Z Bioengineered. 2021; 12(1):6878-6890.

PMID: 34519628 PMC: 8806872. DOI: 10.1080/21655979.2021.1973207.

MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.

Guo Z, Sun Q, Liao Y, Liu C, Zhao W, Li X J Cell Mol Med. 2020; 24(15):8350-8362.

PMID: 32575164 PMC: 7412694. DOI: 10.1111/jcmm.15247.

References

Kennedy B, Harris R . Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer. Inflammopharmacology. 2018; . DOI: 10.1007/s10787-018-0489-6. View

Chiu P, Ngan Y, Khoo U, Cheung A . Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology. 2001; 38(3):243-9. DOI: 10.1046/j.1365-2559.2001.01065.x. View

Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H . Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem. 2001; 276(25):22032-40. DOI: 10.1074/jbc.M011369200. View

Li W, Liu C, Zhao C, Zhai L, Lv S . Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer. Int J Oncol. 2016; 48(3):1155-64. DOI: 10.3892/ijo.2016.3319. View

Zhao R, Qin W, Qin R, Han J, Li C, Wang Y . Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp. Clin Proteomics. 2017; 14:20. PMC: 5442857. DOI: 10.1186/s12014-017-9155-z. View

Fock V, Plessl K, Fuchs R, Dekan S, Milla S, Haider S . Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles. Hum Reprod. 2015; 30(4):789-99. DOI: 10.1093/humrep/dev027. View

Na Q, Wang D, Song W . Underexpression of 4 placenta-associated microRNAs in complete hydatidiform moles. Int J Gynecol Cancer. 2012; 22(6):1075-80. DOI: 10.1097/IGC.0b013e3182574439. View

Pike L, Casey L . Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry. 2002; 41(32):10315-22. DOI: 10.1021/bi025943i. View

Kan M, Yamamoto E, Niimi K, Tamakoshi K, Sekiya Y, Nishino K . Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study. J Reprod Med. 2018; 61(7-8):373-379. View

10.

Maeda T, Hobbs R, Pandolfi P . The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res. 2005; 65(19):8575-8. DOI: 10.1158/0008-5472.CAN-05-1055. View

11.

Yamamoto E, Niimi K, Kiyono T, Yamamoto T, Nishino K, Nakamura K . Establishment and characterization of cell lines derived from complete hydatidiform mole. Int J Mol Med. 2017; 40(3):614-622. PMC: 5547987. DOI: 10.3892/ijmm.2017.3067. View

12.

Wang Y, Zhao J, Xu Y, Wu W, Zhang H . miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells. Int J Gynecol Cancer. 2016; 27(2):364-374. DOI: 10.1097/IGC.0000000000000861. View

13.

Maryu G, Matsuda M, Aoki K . Multiplexed Fluorescence Imaging of ERK and Akt Activities and Cell-cycle Progression. Cell Struct Funct. 2016; 41(2):81-92. DOI: 10.1247/csf.16007. View

14.

Kaneki E, Kobayashi H, Hirakawa T, Matsuda T, Kato H, Wake N . Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Cancer Sci. 2010; 101(7):1717-21. PMC: 11159630. DOI: 10.1111/j.1349-7006.2010.01602.x. View

15.

Li W, Dai H, Ou Q, Zuo G, Liu C . Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Tumour Biol. 2015; 37(5):5885-95. DOI: 10.1007/s13277-015-4456-1. View

16.

Rahat B, Najar R, Hamid A, Bagga R, Kaur J . The role of aberrant methylation of trophoblastic stem cell origin in the pathogenesis and diagnosis of placental disorders. Prenat Diagn. 2016; 37(2):133-143. DOI: 10.1002/pd.4974. View

17.

Zhou L, Jia S, Ding G, Zhang M, Yu W, Wu Z . Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma. J Cancer. 2019; 10(21):5031-5040. PMC: 6775620. DOI: 10.7150/jca.31191. View

18.

Zhong M, Bian Z, Wu Z . miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem. 2013; 31(2-3):209-18. DOI: 10.1159/000343362. View

19.

Wang Y, Fan H, Zhao G, Liu D, Du L, Wang Z . miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J. 2012; 279(24):4510-24. DOI: 10.1111/febs.12037. View

20.

Yoshida T, Zhang G, Haura E . Targeting epidermal growth factor receptor: central signaling kinase in lung cancer. Biochem Pharmacol. 2010; 80(5):613-23. DOI: 10.1016/j.bcp.2010.05.014. View